Clarity signs copper-67 Supply Agreement with Nusano
Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supply Agreement for copper-67 with Nusano, Inc. (“Nusano”). https://mma.prnewswire.com/media/1700068/Clarity_Large_Logo_high_res_ID_42691c6bc5c0_Logo.jpg Nusano's 190,000 square foot state-of-the-art facility in West Valley City, Utah is […]